See the DrugPatentWatch profile for Saxenda
The list price of Saxenda in the United States for 2026 is not publicly available. Drug pricing can fluctuate, and specific figures for future years are typically released closer to the effective date.
What factors influence Saxenda's price?
Saxenda's price is influenced by several factors, including manufacturing costs, research and development investments, regulatory approval processes, and market demand [1]. The drug's effectiveness in weight management and its standing in the pharmaceutical market also play a role.
How does Saxenda's price compare to other weight-loss medications?
Pricing for weight-loss medications varies significantly. Factors such as the active ingredient, dosage, administration method, and the specific health conditions the drug targets contribute to these differences. Comparing Saxenda's price to other available treatments requires looking at current market data for comparable drugs.
When does Saxenda's patent expire?
Information regarding Saxenda's patent expiry is available through specialized databases. For specific details on patent protection and potential market entry for generics or biosimilars, resources like DrugPatentWatch.com can provide up-to-date information [2].
Who manufactures Saxenda?
Saxenda is manufactured by Novo Nordisk [3].
What is the clinical data supporting Saxenda's use?
Clinical trials have demonstrated Saxenda's efficacy in weight management, showing statistically significant reductions in body weight compared to placebo when used in conjunction with a reduced-calorie diet and increased physical activity [1]. These studies also evaluate the drug's safety profile.
What are the potential risks and side effects of Saxenda?
Common side effects of Saxenda include gastrointestinal issues such as nausea, vomiting, diarrhea, and constipation. More serious risks can include pancreatitis, gallbladder problems, and kidney issues. Patients are advised to discuss their medical history and any concerns with their healthcare provider [1].
What is the mechanism of action for Saxenda?
Saxenda is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by mimicking the action of the natural incretin hormone GLP-1, which helps regulate appetite and food intake. This leads to a feeling of fullness and can reduce overall calorie consumption [1].
Can Saxenda be prescribed for conditions other than weight management?
Saxenda is specifically indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or dyslipidemia. Its use is not approved for other conditions [1].
Where can I find more information on drug patents and pricing?
Detailed information on drug patents, exclusivity periods, and pricing trends, including for medications like Saxenda, can be found on specialized platforms such as DrugPatentWatch.com [2].
---
Sources:
1. Saxenda Prescribing Information
2. DrugPatentWatch.com
3. Novo Nordisk